Skip to main content
. 2021 Mar 12;10(6):1194. doi: 10.3390/jcm10061194

Table 5.

Effect of hypertension and hypertension-related conditions on severe outcomes 1 among patients hospitalized for COVID-19.

Chronic Condition Evaluated Crude Analysis Partial-Adjusted Analysis 2 Fully-Adjusted Analysis 3
RR (95% CI) p-Value RR (95% CI) p-Value RR (95% CI) p-Value
Severe cases
Hypertension 1.98 (1.48–2.67) <0.001 1.31 (0.96–1.79) 0.092 1.19 (0.86–1.65) 0.298
Cardiovascular disease 1.99 (1.44–2.76) <0.001 1.20 (0.84–1.72) 0.321 1.14 (0.79–1.65) 0.474
Cerebrovascular disease 2.30 (1.38–3.85) 0.002 1.34 (0.78–2.30) 0.289 1.26 (0.73–2.18) 0.407
Chronic renal disease 2.07 (1.37–3.12) <0.001 1.21 (0.78–1.87) 0.392 1.13 (0.73–1.76) 0.581
ICU admission
Hypertension 1.70 (1.18–2.45) 0.004 1.42 (0.96–2.10) 0.077 1.42 (0.94–2.13) 0.095
Cardiovascular disease 1.33 (0.85–2.06) 0.210 1.07 (0.66–1.72) 0.790 1.05 (0.64–1.70) 0.856
Cerebrovascular disease 1.03 (0.42–2.52) 0.951 0.91 (0.36–2.30) 0.850 0.87 (0.34–2.23) 0.778
Chronic renal disease 1.07 (0.56–2.04) 0.842 0.86 (0.44–1.69) 0.662 0.82 (0.41–1.62) 0.565
Exitus
Hypertension 2.78 (1.86–4.16) <0.001 1.38 (0.91–2.09) 0.131 1.15 (0.75–1.79) 0.518
Cardiovascular disease 3.58 (2.39–5.35) <0.001 1.84 (1.21–2.81) 0.005 1.45 (0.92–2.30) 0.111
Cerebrovascular disease 4.55 (2.66–7.78) <0.001 2.23 (1.27–3.91) 0.005 1.80 (1.00–3.23) 0.049
Chronic renal disease 3.16 (1.95–5.12) <0.001 1.51 (0.92–2.50) 0.105 1.10 (0.65–1.86) 0.714

1 Severe outcomes include patients who were admitted to intensive care unit or died. 2 Adjusted for sociodemographic characteristics: sex, age, country of origin, municipality population and annual taxable income level. 3 Additionally adjusted for health-related characteristics: cardiovascular disease, cerebrovascular disease, chronic kidney disease, primary health care visits in prior 12 months, hospitalization in prior 12 months, smoking status, and other major chronic conditions. RR, relative risk; CI, confidence interval; ICU, intensive care unit.